𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vitamin D Inhibition of the Prostaglandin Pathway as Therapy for Prostate Cancer

✍ Scribed by David Feldman; Aruna Krishnan; Jacqueline Moreno; Srilatha Swami; Donna M. Peehl; Sandy Srinivas

Book ID
109381299
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
43 KB
Volume
65
Category
Article
ISSN
0029-6643

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The inhibition of the paracrine progress
The inhibition of the paracrine progression of prostate cancer as an approach to early therapy of prostatic carcinoma
✍ Dr. Christopher Logothetis; Naseema Hoosein πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 586 KB

The prevalence of neural elements in prostatic carcinoma and their effects on the behavior of the lesion have recently been recognized. Recent reports suggest that chromogranin-A-and neuron-specific enolase-expressing tumors have an earlier progression and a lower response rate to hormonal therapy.

Prostate cancer laterality as a rational
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer
✍ Vladimir Mouraviev; Janice M. Mayes; Leon Sun; John F. Madden; Judd W. Moul; Tho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Early detection of small‐volume prostate cancer (PCa) has led to the concept of focal therapy to treat PCa as an organ‐sparing, minimally invasive procedure. The authors sought to determine the frequency of unilateral cancers in the contemporary prostate‐specific antigen